Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Braden's Hope For Childhood Cancer is a non-profit organization dedicated to raising awareness and funding for pediatric cancer research. Founded in 2010 by Deliece Hofen following her son's diagnosis, the foundation focuses on advancing targeted therapies to improve survival rates and reduce treatment toxicities for children. It primarily funds research grants at leading institutions, including Children's Mercy Hospital, the University of Kansas Cancer Center, and the Children's Hospital of Philadelphia. To date, the organization has committed over $5.5 million to research projects targeting indications such as neuroblastoma, leukemia, and Ewing sarcoma. Through its Research Review Board, Braden's Hope ensures that funded studies are feasible and aligned with its mission to provide better treatment options for children.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Braden's Hope Foundation.